Vitamin E TPGS Used as Emulsifier in the Preparation of Nanoparticulate Systems

被引:21
作者
Bernabeu, Ezequiel [1 ]
Chiappetta, Diego A. [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Biochem, Dept Pharmaceut Technol, CONICET, RA-1113 Buenos Aires, DF, Argentina
关键词
Biodegradable Polymeric Nanoparticles; TPGS-Copolymers; TPGS-Drug Conjugates; Vitamin E TPGS; D-ALPHA-TOCOPHERYL; POLYETHYLENE-GLYCOL SUCCINATE; BLOOD-BRAIN-BARRIER; COATED PLGA NANOPARTICLES; CACO-2 CELL MONOLAYERS; TARGETED DRUG-DELIVERY; BREAST-CANCER CELLS; IN-VITRO; P-GLYCOPROTEIN; POLYMERIC NANOPARTICLES;
D O I
10.1166/jbt.2013.1076
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
In recent years, nanoparticulate systems have matured from simple devices to multifunctional and more complex systems. They are biodegradable, stable in blood, non-toxic, and non immunogenic construct, capable of delivering drugs in a specific site, thereby improving efficacy. Their capabilities as drug delivery system and the interaction with the biological cells in the target tissue are dependent on their physicochemical properties such as particles size, size distribution, surface charge and morphology. Polymeric nanoparticles are usually produced by two classical methods: nanoprecipitation and emulsion-solvent evaporation technique. In such process, a number of preparation parameters can affect the nature of the nanoparticles as: drug, polymer concentration, temperature, solvent volume, aqueous:organic phase ratio, type and concentration of emulsifier and so forth. One of the most important formulation parameters involves the emulsifier, which is necessary as surfactant stabilizer in the process to form nanoparticles. D-a-tocopheryl polyethylene glycol (PEG) 1000 succinate (TPGS) is a water soluble derivate of natural source vitamin E. It is amphipathic and hydrophilic, exhibiting the characteristics of a typical surface-active agent. This review summarizes recently available information regarding the emulsifying effects of TPGS on the preparation, characterization, in vitro release and in vivo performance of the nanoparticulate systems, and the advantages of TPGS-drug conjugates.
引用
收藏
页码:122 / 134
页数:13
相关论文
共 113 条
[1]
Recent advances in stealth coating of nanoparticle drug delivery systems [J].
Amoozgar, Zohreh ;
Yeo, Yoon .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2012, 4 (02) :219-233
[2]
Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy [J].
Anbharasi, Vanangamudi ;
Cao, Na ;
Feng, Si-Shen .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 94A (03) :730-743
[3]
D-ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL-1000 SUCCINATE ENHANCES THE ABSORPTION OF VITAMIN-D IN CHRONIC CHOLESTATIC LIVER-DISEASE OF INFANCY AND CHILDHOOD [J].
ARGAO, EA ;
HEUBI, JE ;
HOLLIS, BW ;
TSANG, RC .
PEDIATRIC RESEARCH, 1992, 31 (02) :146-150
[4]
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (03) :375-388
[5]
Vitamin E analogues as inducers of apoptosis: structure-function relation [J].
Birringer, M ;
EyTina, JH ;
Salvatore, BA ;
Neuzil, J .
BRITISH JOURNAL OF CANCER, 2003, 88 (12) :1948-1955
[6]
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption [J].
Bogman, K ;
Zysset, Y ;
Degen, L ;
Hopfgartner, G ;
Gutmann, H ;
Alsenz, J ;
Drewe, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (01) :24-32
[7]
The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins [J].
Bogman, K ;
Erne-Brand, F ;
Alsenz, J ;
Drewe, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (06) :1250-1261
[8]
Safety considerations for statins [J].
Bolego, C ;
Baetta, R ;
Bellosta, S ;
Corsini, A ;
Paoletti, R .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (06) :637-644
[9]
Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[10]
BRUEGGEMEIER RW, 1990, CANCER RES, V50, P3652